Cat. No. |
Product Name |
Information |
PC-20978 |
ZINC621433144
D4 agonist
|
ZINC621433144 is a Gi-biased, high-affinity full agonist of dopamine D4 receptor with Ki of 4.3 nM and cAMP EC50 of 0.18 nM. |
PC-20865 |
GR-103691
D3 receptor antagonist
|
GR-103691 is a potent, selective dopamine D3 receptor antagonist with binding Ki of 0.4 nM, >100-fold selectivity over D1 and D4 receptors. |
PC-20864 |
CJB 090
D3 receptor agonist
|
CJB 090 (CJB090) is a selective partial agonist of dopamine D3 receptor with binding Ki of 0.6 nM, CJB 090 is 97-fold selective for D3 receptors over D2. |
PC-20863 |
NGB-2904
D3 receptor antagonist
|
NGB-2904 is a potent, highly selective dopamine D3 receptor antagonist with Ki of 2.0 nM for hD3, 56-fold selectivity over hD2. |
PC-20862 |
PG01037
D3 receptor antagonist
|
PG01037 is a potent selective dopamine D3 receptor antagonist with binding Ki of 0.7 nM, displays 133- and 540-fold selectivity over D2 and D4 receptors, respectively. |
PC-36061 |
Compound 621433144
|
Compound 621433144 (ZINC000621433144, Z3269026405) is a potent, selective full agonist of the D4 receptor with 2,500-fold subtype selectivity. |
PC-43162 |
Apomorphine hydrochloride hemihydrate
|
Apomorphine hydrochloride hemihydrate is a non-selective dopamine agonist which activates both D1-likeand D2-like receptors, with some preference for the latter subtypes.. |
PC-43088 |
SKF 38393 hydrochloride
|
SKF 38393 is a potent, selective prototypical D1-like dopamine receptor with Ki of 1 and 0.5 nM for D1 and D5 receptors, shows little to no affinity for D2, D3 and D4 receptors. |
PC-63114 |
SKF-38393 hydrobromide
|
SKF-38393 is a potent, selective D1/D5 receptor partial agonist with Ki of 1 and 0.5 nM, respectively. |
PC-63037 |
Bromocriptine
|
Bromocriptine (2-Bromoergocriptine. |
PC-62632 |
PF-06669571
|
PF-06669571 (PF 6669571) is a novel dopamine D1 receptor (D1R) partial agonist with Ki of 10 nM, demonstrates efficacy in pre-clinical models of Parkinson’s disease symptoms.
. |
PC-60812 |
SCH39166
|
A potent, selective D1 dopamine receptor antagonist with Ki of 3.6 nM, >300-fold selectivity over D2 and 5-HT2 receptors. |